News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Moran Michael Shawn
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 742 shares
@ $45.03, valued at
$33.4k
|
|
| 02/01/2022 |
4
| Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 210 shares
@ $45.94, valued at
$9.6k
|
|
| 01/11/2022 |
4
| Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 90 shares
@ $50.63, valued at
$4.6k
|
|
| 01/07/2022 |
4
| Moran Michael Shawn (EVP, Chief Commercial Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,511 shares
@ $50.69, valued at
$76.6k
|
|
| 10/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|